New Study Reveals How the C/G Fusion Hijacks DNA Methylation and Chromatin Architecture to Drive Aggressive AMKL Pediatric ...

This Research Topic is Volume II of a series. The previous volume, which has attracted over 21k views can be found here:Transforming Chronic Disease ...

One of the emerging leaders in pharmacology and drug discovery, Victor Omoboyede, has developed a patented bioinformatics ...

Multiple myeloma is an incurable plasma cell malignancy despite major therapeutic advances. A recent review by Chinese ...

As part of the PDAOAI initiative, Oncotelic has curated a comprehensive TGF-β literature corpus comprising more than 125,000 PubMed abstracts, representing the near-totality of scientific knowledge ...

The field of plant–microbe interactions has seen remarkable transformation with the recognition that plants harbour diverse microbial communities—including ...

Biopharma may see a happier year ahead in 2026 than in recent years, according to analysts at William Blair. For one thing, the industry’s top stocks have recovered from lows that stretched into last ...

Multiple myeloma (MM) is the second most common hematologic malignancy, characterized by the uncontrolled growth of plasma cells and progressive ...

M42 is committed to the sustainable future of global health – from Abu Dhabi to the world. The company’s strategy involves leveraging technology not as a mere tool but as a transformative force in ...

A research team has made a significant breakthrough in understanding the molecular mechanisms that drive the accumulation of glucosinolates (GSLs) in ...

Diets, Food Health Benefits, Diseases, Therapy Share and Cite: Menkovska, M. and Raza, S. (2025) Human Gut Microbiome in ...

The Hong Kong University of Science and Technology (HKUST), in collaboration with the Southern Marine Science and Engineering ...